A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Recruiting

Phase 1

PF-08052667 & BCG & SasanlimabA Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Sponsor:

Pfizer

Code:

NCT07206225

Conditions

Non-muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08052667

Sasanlimab

BCG

PF-02921367

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by Pfizer on 2025-10-31.